Table 3 Sensitivity and specificity of each criterion of Gerami and Gaiser in differentiating dysplastic nevi and early-stage acral and cutaneous melanomas
Sensitivity | Specificity | |
|---|---|---|
Gerami’s criteria | ||
RREB1 > CEP6 (> 55%) | 15.2% | 100% |
RREB1 > 2 (> 29%) | 74.6% | 94.0% |
MYB<CEP6 (> 40%) | 40.7% | 98.0% |
CCND1 > 2 (> 38%) | 91.5% | 94.0% |
Totala | 94.9% | 94.0% |
Gaiser’s criteria | ||
RREB1 aberrant (> 63%) | 47.5% | 94.0% |
MYB<CEP6 (> 31%) | 50.8% | 98.0% |
MYB ≥ 2.5 | 47.5% | 94.0% |
CCND1 ≥ 2.5 | 88.1% | 94.0% |
Totala | 93.2% | 90.0% |